Literature DB >> 6486025

Prevalence and prognosis of exercise-induced nonsustained ventricular tachycardia in apparently healthy volunteers.

J L Fleg, E G Lakatta.   

Abstract

Although exercise-induced ventricular tachycardia (VT), whether sustained or nonsustained, is usually associated with significant organic heart disease, its prevalence, associated characteristics and prognostic significance in an asymptomatic, unreferred community-dwelling population are unknown. Therefore, the prevalence of VT associated with maximal treadmill exercise was assessed in 597 male and 325 female volunteers, aged 21 to 96 years (mean +/- standard deviation 54 +/- 16), from the Baltimore Longitudinal Study on Aging who were without apparent heart disease. Ten subjects, 7 men and 3 women, with exercise-induced VT were identified, representing 1.1% of those tested; only 1 was younger than 65 years. All episodes of VT were asymptomatic and nonsustained. In 9 of 10 subjects, VT developed at or near peak exercise. The longest run of VT was 6 beats; multiple runs of VT were present in 4 subjects. Two subjects had exercise-induced ST-segment depression, but subsequent exercise thallium scintigraphic results were negative in each. Compared with a group of age- and sex-matched control subjects, those with asymptomatic, nonsustained VT displayed no difference in exercise duration, maximal heart rate, or the prevalence of coronary risk factors or exercise-induced ischemia as measured by electrocardiography and thallium scintigraphy. Over a mean follow-up period of 2 years, no subject has developed symptoms of heart disease or experienced syncope or sudden death. Thus, exercise-induced VT in apparently healthy subjects occurs almost exclusively in the elderly, is limited to short, asymptomatic runs of 3 to 6 beats usually near peak exercise, and does not portend increased cardiovascular morbidity or mortality rates over a 2-year period of observation.

Entities:  

Mesh:

Year:  1984        PMID: 6486025     DOI: 10.1016/s0002-9149(84)80204-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Non-invasive risk stratification: prognostic implications of exercise testing.

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-03

2.  Prevalence and prognostic significance of exercise-induced nonsustained ventricular tachycardia in asymptomatic volunteers: BLSA (Baltimore Longitudinal Study of Aging).

Authors:  Joseph E Marine; Veena Shetty; Grant V Chow; Jeanette G Wright; Gary Gerstenblith; Samer S Najjar; Edward G Lakatta; Jerome L Fleg
Journal:  J Am Coll Cardiol       Date:  2013-06-07       Impact factor: 24.094

3.  Ventricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic chagasic cardiomyopathy and ventricular arrhythmias.

Authors:  A A de Paola; J A Gomes; A B Terzian; M H Miyamoto; E E Martinez Fo
Journal:  Br Heart J       Date:  1995-09

Review 4.  The management of ventricular arrhythmias in older patients after CAST.

Authors:  W S Aronow
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

Review 5.  Epidemiology of arrhythmias and conduction disorders in older adults.

Authors:  Grant V Chow; Joseph E Marine; Jerome L Fleg
Journal:  Clin Geriatr Med       Date:  2012-11       Impact factor: 3.076

6.  Diagnostic usefulness of graded exercise testing in pediatric supraventricular tachycardia.

Authors:  David E Draper; Niels G Giddins; Joy McCort; Gil J Gross
Journal:  Can J Cardiol       Date:  2009-07       Impact factor: 5.223

7.  Exercise induced non-sustained ventricular tachycardia and indication for invasive management.

Authors:  Shahriar Dadkhah; Samaneh Dowlatshahi; Korosh Sharain; Roza Sharain
Journal:  Clin Med Insights Cardiol       Date:  2011-11-17

8.  Temporal response of ectopic activity in guinea pig ventricular myocardium in response to isoproterenol and acetylcholine.

Authors:  Amara Greer-Short; Steven Poelzing
Journal:  Front Physiol       Date:  2015-10-20       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.